Evidence map›Paper›PMID 21972294›Full record

ArticleBlood2011

LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function.

Natalie M Reisman, Tamara L Floyd, Maylene E Wagener, Allan D Kirk, Christian P Larsen, Mandy L Ford

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2015
    Trial
  2. Best practices in mouse models of skin transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Memory T cell-mediated rejection is mitigated by FcγRIIB expression on CD8American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Natalie M ReismanEmory Transplant Center, Atlanta, GA 30322, USA.
Tamara L Floyd
Maylene E Wagener
Allan D Kirk
Christian P Larsen
Mandy L Ford
Emory Healthcare · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Activation, Apathy, Anergy and Apoptosis in TransplantationR37AI040519 · NIAID · EMORY UNIVERSITY · PI LARSEN, CHRISTIAN P. · 2007 to 2016
$4.1M
Determinants of T Cell Fate in Transplantation ToleranceR01AI073707 · NIAID · EMORY UNIVERSITY · PI FORD, MANDY L · 2008 to 2021
$4.0M
ACTIVATION/APATHY/ANERGY/APOPTOSIS IN TRANSPLANTATIONR01AI040519 · NIAID · EMORY UNIVERSITY · PI LARSEN, CHRISTIAN P · 1997 to 2006
$2.9M
Donor-Reactive Memory Responses and Recall Requirements in TransplantationR56AI081789 · NIAID · EMORY UNIVERSITY · PI FORD, MANDY L · 2009 to 2009
$349k
NCATS NIH HHS UL1 TR000454NIAID NIH HHS AI073707NIAID NIH HHS AI40519NIAID NIH HHS AI81789NIAID NIH HHS R01 AI040519NIAID NIH HHS R01 AI073707NIAID NIH HHS R37 AI040519NIAID NIH HHS R56 AI081789
6 · The paper itself

Abstract

Despite encouraging results using lymphocyte function antigen-1 (LFA-1) blockade to inhibit BM and solid organ transplantation rejection in nonhuman primates and humans, the precise mechanisms underlying its therapeutic potential are still poorly understood. Using a fully allogeneic murine transplantation model, we assessed the relative distribution of total lymphocyte subsets in untreated versus anti-LFA-1-treated animals. Our results demonstrated a striking loss of naive T cells from peripheral lymph nodes, a concomitant gain in blood after LFA-1 blockade, and a shift in phenotype of the cells remaining in the node to a CD62LloCD44hi profile. We determined that this change was due to a specific enrichment of activated, graft-specific effectors in the peripheral lymph nodes of anti-LFA-1-treated mice compared with untreated controls, and not to a direct effect of anti-LFA-1 on CD62L expression. LFA-1 blockade also resulted in a dramatic increase in the frequency of CD4+ FoxP3+ regulatory T cells in graft-draining nodes. Our results suggest that the differential impact of LFA-1 blockade on the distribution of naive versus effector and regulatory T cells may underlie its ability to inhibit alloreactive T-cell responses after transplantation.

Indexed as

AbataceptAnimalsAntibodiesCell ProliferationDown-RegulationDrug Evaluation, PreclinicalDrug SynergismFemaleImmunoconjugatesLymph NodesLymphocyte CountLymphocyte Function-Associated Antigen-1MaleMiceMice, Inbred BALB CMice, Inbred C57BLAbataceptAntibodiesImmunoconjugatesLymphocyte Function-Associated Antigen-1

Identifiers

PMID21972294
PMCPMC3228500
OpenAlexW2085471242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.